Transparency International Questions $250 Million COVID Vaccine Buying By Pakistan

Transparency International is questioning Pakistan’s decision to by COVID-19 Vaccine, it has expressed concerns over the purchase of $250 million worth of coronavirus vaccine by Pakistan

In a letter to Prime Minister Imran Khan, Chairman Transparency International Sohail Muzaffar has said that withholding details of vaccine rates or tenders is a violation of PEPRA rules.

He said under Rule No 47 of the PEPRA rules, any organization purchasing the vaccine was bound to upload details of the transaction on its website. According to a report, the price of each dose of vaccine ranges between $4 and $37 the world over. 

In this connection, the PEPRA director-general had also written a letter to the secretaries of all ministries on October 28, 2020. In a letter to PM Imran, TI Chairman Sohail Muzaffar wrote that his organization was playing its role in ensuring rule of law in Pakistan. 

Muzaffar said that implementation of Rule No 47 of the PEPRA rules was imperative if chances of corruption were to be eliminated in any type of sale and purchase.

Earlier, on Thursday, Pakistan had announced it would purchase 1.2 million doses of coronavirus vaccine from Chinese manufacturer Sinopharm. Confirming the news on Twitter, Federal Science Minister Fawad Chaudhry had said, “The Cabinet Committee has decided to initially purchase 1.2 million doses of the vaccine from the Chinese company Sinopharm, which will be provided free of cost to frontline workers in the first quarter of 2021.”

Leave a Reply

Your email address will not be published. Required fields are marked *